Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 8-K Event Other events
  4. 8-K Event Executive or director change
  5. 8-K Event Executive or director change
  6. 8-K Event Results of operations
  7. 8-K Event Material agreement
  8. 8-K Event Executive or director change · Other events
  9. 8-K Event Results of operations
  10. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Shareholder vote results
  13. 8-K Event Results of operations
  14. DEF 14A Proxy Proxy Statement
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 8-K Event Material agreement · Agreement ended · Results of operations · Unregistered share sale · Regulation FD disclosure
  18. 8-K Event Other events
  19. 8-K Event Results of operations
  20. 8-K Event Results of operations

Page 2 of 17 · 336 filings